Objective Neonatal hyperthyroidism may be caused by a permanent non-autoimmune
genetic disorder or, more frequently, by maternally transmitted high serum TRAb levels …

Objective Hyperthyroidism in neonates born to mothers with Graves' disease (GD) can be
associated with significant morbidity and mortality, but is still overlooked by clinicians …

Fetal and neonatal autoimmune hyperthyroidism is a rare, serious but transient disorder.
Early diagnosis and treatment are key objectives for an optimal prognosis and the well …

Context: Neonatal hyperthyroidism was first described in 1912 and in 1964 was shown to be
linked to transplacental passage of maternal antibodies. Few multicenter studies have …

Neonatal hyperthyroidism has mostly been described in the context of maternal Graves'
disease. It has been estimated that about 0.2% of pregnant women have Graves' disease; …

Introduction Neonatal hyperthyroidism mainly occurring in the children born to mothers with
Graves' disease (GD). The influence of maternal GD on the newborn's thyroid function …

Fetal and neonatal dysfunctions include rare serious disorders involving abnormal thyroid
function during the second half of gestation, which may persist throughout life, as for most …

Background: Overt neonatal Graves' disease is rare, but may be severe, even life
threatening, with deleterious effects on neural development. The main objective of this study …

Objective To assess maternal thyroid-stimulating immunoglobulin (TSI) as a predictor of
neonatal thyroid hyperthyroidism in pregnancies complicated by Graves' disease. Methods …

Neonatal thyrotoxicosis (hyperthyroidism) is less prevalent than congenital hypothyroidism;
however, it can lead to significant morbidity and mortality if not promptly recognized and …